Physiological limits of capillary refill time: a human endotoxemia study
In brief
Capillary refill time peaks at 8 s then falls to 1 s in one inflammation
In healthy volunteers given endotoxin, finger capillary refill time rose from a baseline of 3.5 s to 8.3 s at 1.5 hours, then shortened to 1.3 s by 5 hours, crossing the traditional 3-second cut-off in both directions. Because values depend heavily on skin temperature and vary little between people, a single measurement is unreliable; tracking changes over time may be more informative, but patient studies are still needed.
- Journal
- Critical care (London, England) (Q1)
- Published
- 31 August 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Hugo Gustavsson, Rani Toll, Sara Fahlander, Frida Meyer, Birgitta Ölwegård, Martin Hultman, et al.
- PMID
- 42706575
- DOI
- 10.1186/s13054-026-06247-8
Why clinicians should know about it
- Picked for Anatomy (top studies of the week, 13 September 2026): Capillary refill physiology, not anatomical variation
- Picked for Critical Care and Intensive Care Medicine (top studies of the week, 13 September 2026): Finger qCRT crosses 3‑s threshold during acute inflammation
Abstract
BACKGROUND: The capillary refill test is a widely used bedside marker of tissue perfusion, but its reliability during acute inflammation is not well characterised. The guiding 3-s threshold rests on limited physiological validation and on visual assessment with high observer variability. How finger capillary refill time (CRT) behaves during acute inflammation remains unclear. Using quantitative capillary refill time (qCRT), which removes observer variability, we determined how finger qCRT behaves over an acute inflammatory episode in a controlled human endotoxemia model. METHODS: In a double-blind, randomized, crossover study, 25 healthy volunteers received an intravenous bolus of Escherichia coli lipopolysaccharide (0.8 ng/kg) or saline placebo. Finger qCRT was measured by polarized reflectance imaging at baseline and 1.5, 3.5, and 5 h, and analysed with censored (Tobit) mixed-effects models adjusting for physiological covariates. RESULTS: Finger qCRT followed a biphasic course that crossed the 3-s clinical threshold in both directions within a single inflammatory episode. From a baseline near 3.5 s, it was prolonged to 8.31 s at 1.5 h, with 14 of 25 reaching the 10-s ceiling, then shortened to 1.27 s at 5 h during persisting systemic inflammation. Estimated marginal contrasts against placebo were 4.13 s and - 3.10 s at these time points (both p < 0.0001). The early prolongation persisted after adjustment for physiological covariates, whereas the late shortening was attenuated after adjustment for concurrent thermoregulatory and haemodynamic covariates. Skin temperature was the strongest qCRT covariate, with each standard-deviation increase associated with a 1.62 s decreased qCRT. No formal mediation analysis was performed. Resting values were highly variable, with between-subject differences explaining a minority of total variance (intraclass correlation 0.30). CONCLUSIONS: Finger qCRT tracks the course of acute systemic inflammation but crosses the 3-s clinical threshold in both directions within a single episode. Because between-subject differences account for a minority of total variance and resting values depend strongly on skin temperature, a single value against a fixed threshold is unreliable, whereas change over time within a participant is informative. These findings in healthy participants are not directly generalizable to septic shock and require confirmation in prospective patient studies before informing clinical practice. TRIAL REGISTRATION: ClinicalTrials.gov NCT06618716. Registered September 27, 2024.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.